Company profile
Agios Pharmaceuticals, Inc. Insider Trading
AGIOEvery SEC Form 4 insider trading filing for Agios Pharmaceuticals, Inc. (AGIO) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001439222
- Filings
- 168
- Insiders
- 17
- Last filing
- 2026-08-04
Activity summary
No discretionary insider buying or selling in the last 30 days. The 1 transaction filed was made under a 10b5-1 plan, scheduled in advance rather than decided on the day.
Three year balance
Buy and sell value by quarter, Q3 23 to Q3 26. Agios Pharmaceuticals, Inc. insiders were net sellers in every quarter shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $6.5M.
90 day insight
Over the last 90 days, Agios Pharmaceuticals, Inc. insiders bought $0 across 48 transactions with no open-market sales.
- Most active insider: Gheuens Sarah with 6 transactions totaling $1.1M.
- Largest single sale: $914K by Gheuens Sarah on Aug 4, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Gheuens Sarah | AGIO | Sale10b5 | 30,000 | $30.48 | $914K |
| Jul 8, 2026 | Backstrom Jay T. | AGIO | Award | 1,447 | — | — |
| Jul 8, 2026 | Backstrom Jay T. | AGIO | Option Exercise | 1,447 | — | — |
| Jul 1, 2026 | Gheuens Sarah | AGIO | Sale10b5 | 4,007 | $37.56 | $151K |
| Jul 1, 2026 | Gheuens Sarah | AGIO | Option Exercise | 8,375 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=AGIO" \
-H "X-Api-Key: $KEY"Institutional Ownership
Top 13F-HR holders of Agios Pharmaceuticals, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →